Loading clinical trials...
Loading clinical trials...
The goal of this research study is to evaluate, in the open-label extension phase, the effectiveness, tolerability and safety of rivastigmine capsules in males and females between the ages of 50 and 8...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novartis
NCT07545473 · Dementia, Neurodegenerative Diseases, and more
NCT03653156 · Mild Cognitive Impairment(MCI), Alzheimer Disease, Late Onset, and more
NCT06416371 · Cerebral Small Vessel Diseases, Lacunar Stroke, and more
NCT06903078 · Herpes Zoster (HZ), Vascular Dementia
NCT07259499 · Alzheimer s Disease, Vascular Dementia, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions